Label free detection technology is a drug discovery tool that can be used for the detection of the molecular interactions. Unlike enzyme linked immunoassay (ELISA) and flow cytometry, this tool helps in the investigation of molecular interactions without spatial interference, auto fluorescent and quenching effects. The label free detection technology is specifically designed to detect endogenous targets in assays by eliminating the use of reporter labels like dyes, tags, or specialized reagents.
View Exclusive Global Strategic Business Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4502
Label free detection techniques offers effectively manage complexity of multiple signaling pathways and also eliminate the use of auto fluorescent, spatial interference which would increase the usage of label free detection techniques hence drives the market growth. In addition, rising research and development activities in pharmaceutical, biotechnology companies and in academic institutions coupled with rising pharmaceutical outsourcing activities will further stimulate the uptake of label free detection technologies hence drives the market growth. Moreover, many private and government organizations are organizing seminars to increase the awareness about label free detection techniques among the end users which would drive the market growth.
Consistent efforts of key companies to develop novel label free detection techniques further augment the label free detection techniques market growth. For example, Corning Incorporated offers Epic System that performs label free biochemical and cell based assays in a 384 well micro-plate format. This system enables researchers to obtain more physiologically relevant data within short period of time. Thus, these types of efforts will establish healthy platform to develop the market which would drive the growth of the market. However, high cost of the label free detection instruments restrains the growth of the market. In addition, lack of knowledge and awareness of label free detection techniques further act as the potential restraints for the market growth.
Geographically, North America is considered to be the largest market of label free detection techniques owing to the rise in demand of label free detection technologies by pharmaceutical and research centers. In addition, introduction of advanced technology based label free detection instrument further augments the growth of the market in North America. This factor would in turn increase the demand of label free detection technologies hence drive the market growth. Europe considered as second largest market of label free detection techniques.
The market of label free detection technique is witnessing positive growth in Europe due to advancement in label free detection technologies coupled with increasing adoption of label free detection technique in European region. In addition, Asia-Pacific region is the emerging markets for label free detection technique because of rising awareness about label free detection systems coupled with increasing initiatives of governments to improve healthcare infrastructure in Asia-Pacific region.
Some of the key players contributing to the global label free detection technique market comprises Roche Diagnostics, BiOptix Corporation, Ametek, Inc., X-Body Biosciences, Danaher Corporation, Corning, Inc., Corning Incorporated, Bio-Rad Laboratories, Inc., General Electric, Pall Corporation, PerkinElmer, Inc. and others.
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453